Drugmaker Pfizer is warning doctors that it expects to run low on supplies of Bicillin L-A, a long-acting injection of the antibiotic penicillin, the preferred option for treating syphilis during ...
Morning Overview on MSN
A shortage of the only long-acting penicillin is straining care into late 2026
Clinicians across the United States are rationing the only long-acting penicillin approved for syphilis treatment after the manufacturer pushed its next delivery of Bicillin L-A to October 2026 and ...
Drugmaker Pfizer is warning doctors that it expects to run low on supplies of Bicillin L-A, a long-acting injection of the antibiotic penicillin, the preferred option for treating syphilis during ...
Bicillin L-A most recently went into shortage in 2023. During that time, the US Food and Drug Administration has allowed imports of two equivalent products, a French drug called Extencilline, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results